Safety and Efficacy of Staged Percutaneous Coronary Intervention During Index Admission for ST-Elevation Myocardial Infarction With Multivessel Coronary Disease (Insights from the University of Ottawa Heart Institute STEMI Registry)

Russo, Juan; Wells, George; Chong, Aun Yeong; So, Derek; Glover, Chris; Froeschl, Michael; Hibbert, Benjamin; Marquis, Jean-François; Dick, Alexander; Blondeau, M; Bernick, Jordan; Labinaz, Marino; May, Michel R. Le

doi:10.1016/j.amjcard.2015.07.029

Cited by 19 publications

(5 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…IMH is a reperfusion injury occurring when restored blood flow into damaged capillaries extravasates erythrocytes into myocardium[ 121 , 122 ]. CMR-derived IMH was first described in reperfused canine myocardium on ex-vivo T2-weighted spin-echo (T2w-TSE) imaging with excellent agreement with histology (r = 0.96 for IMH extent)[ 123 ].…”

Section: Imh In Amimentioning

confidence: 99%

Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction

Khan¹,

McCann²

2017

WJC

View full text Add to dashboard Cite

Cardiovascular magnetic resonance (CMR) imaging uniquely characterizes myocardial and microvascular injury in acute myocardial infarction (AMI), providing powerful surrogate markers of outcomes. The last 10 years have seen an exponential increase in AMI studies utilizing CMR based endpoints. This article provides a contemporary, comprehensive review of the powerful role of CMR imaging in the assessment of outcomes in AMI. The theory, assessment techniques, chronology, importance in predicting left ventricular function and remodelling, and prognostic value of each CMR surrogate marker is described in detail. Major studies illustrating the importance of the markers are summarized, providing an up to date review of the literature base in CMR imaging in AMI.

show abstract

Section: Imh In Amimentioning

confidence: 99%

Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction

Khan¹,

McCann²

2017

WJC

View full text Add to dashboard Cite

show abstract

“…Częstość niedostatecznie kontrolowanych głównych czynników ryzyka u pacjentów rok po hospitalizacji z powodu ostrego zespołu wieńcowego lub w celu rewaskularyzacji mięśnia sercowego [55][56][57]; *Deklaracja pacjenta lub stężenie tlenku węgla (CO) w wydychanym powietrzu ≥ 10 ppm; **Lata 1997-1998: zalecane stężenie cholesterolu frakcji lipoprotein o niskiej gęstości (LDL) < 3,5 mmol/l (< 135 mg%), 1999-2000: < 3,0 mmol/l (< 115 mg%), 2006-2007: < 2,5 mmol/l (< 100 mg%), 2011-2013: < 1,8 mmol/l (< 70 mg%); BMI -wskaźnik masy ciała; RR -ciśnienie tętnicze krwi rewaskularyzacji). W innych krajach odsetek PCI w ramach II etapu rewaskularyzacji wynosi 15-25% (średnio 20%) [62,63]. W międzynarodowych badaniach wielośrodkowych odsetek pacjentów z ACS wypisywanych ze szpitala bez pełnej rewaskularyzacji mięśnia sercowego wynosi ok. 25% (17% przy definicji istotnego zwężenia jako zwężenia światła naczynia o co najmniej 70%) [14].…”

Section: Specjalistyczna Ambulatoryjnaunclassified

Coordinated care after myocardial infarction. The statement of the Polish Cardiac Society and the Agency for Health Technology Assessment and Tariff System

et al. 2016

View full text Add to dashboard Cite

The in-hospital mortality following myocardial infarction has decreased substantially over the last two decades in Poland. However, according to the available evidence approximately every 10th patient discharged after myocardial infarction (MI) dies during next 12 months. We identified the most important barriers (e.g. insufficient risk factors control, insufficient and delayed cardiac rehabilitation, suboptimal pharmacotherapy, delayed complete myocardial revascularisation) and proposed a new nation-wide system of coordinated care after MI. The system should consist of four modules: complete revascularisation, education and rehabilitation programme, electrotherapy (including ICDs and BiVs when appropriate) and periodical cardiac consultations. At first stage the coordinated care programme should last 12 months. The proposal contains also the quality of care assessment based on clinical measures (e.g. risk factors control, rate of complete myocardial revascularisation, etc.) as well as on the rate of cardiovascular events. The wide implementation of the proposed system is expected to decrease one year mortality after MI and allow for better financial resources allocation in Poland.

show abstract

“…We assumed 20% of the participants would withdraw or be lost to follow-up. This estimate was based on the results of previous studies [ 13 , 14 ]. The software used for the sample size calculation was “xsampsi” from Stata 13.1.…”

Section: Methodsmentioning

confidence: 99%

In-hospital versus after-discharge complete revascularization in patients with ST segment elevation myocardial infarction and multivessel disease. REVIVA-ST trial

Rumiz,

Valero,

Fernandez

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Introduction Complete revascularization (CR) in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), is associated with a reduction in major adverse cardiovascular events (MACE). However, there is uncertainty about whether nonculprit-lesion revascularization should be performed, during index hospitalization or delayed, especially regarding health care resources utilization. In this study, we aimed to evaluate the impact of in-hospital nonculprit-lesion revascularization vs. delayed (after discharge) revascularization on the length of index hospitalization. Methods In this single-center study, we randomly assigned patients with STEMI and MVD who underwent successful culprit-lesion PCI to a strategy of either CR during in-hospital admission or a delayed CR after discharge. The first primary endpoint was the length of hospital stay. The second endpoint was the composite of cardiovascular death, myocardial infarction or ischemia-driven revascularization at 12 months (MACE). Results From January 2018 to December 2022, we enrolled 258 patients (131 allocated to CR during in-hospital admission and 127 to an after-discharge CR). We found a significant reduction in the length of hospital stay in those assigned to after-discharge CR strategy [4 days (3–5) versus 7 days (5–9); p = 0.001]. At 12-month of follow-up, no differences were found in the occurrence of MACE, 7 (5.34%) patients in in-hospital CR and 4 (3.15%) in after-discharge CR strategy; (hazard ratio, 0.59; 95% confidence interval, 0.17 to 2.02; p = 0.397). Conclusions In STEMI patients with MVD, an after-discharge CR strategy reduces the length of index hospitalization without an increased risk of MACE after 12 months of follow-up. Trial registration ClinicalTrials.gov number: NCT04743154.

show abstract

Safety and Efficacy of Staged Percutaneous Coronary Intervention During Index Admission for ST-Elevation Myocardial Infarction With Multivessel Coronary Disease (Insights from the University of Ottawa Heart Institute STEMI Registry)

Cited by 19 publications

References 25 publications

Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction

Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction

Coordinated care after myocardial infarction. The statement of the Polish Cardiac Society and the Agency for Health Technology Assessment and Tariff System

In-hospital versus after-discharge complete revascularization in patients with ST segment elevation myocardial infarction and multivessel disease. REVIVA-ST trial

Contact Info

Product

Resources

About